Pennant Group, Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 58/100
What the filing says
Pennant Group reported Q2 2026 revenue of $298.0M (up 35.8% YoY from $219.5M), driven by 43.2% growth in home health/hospice to $237.8M and 12.6% growth in senior living to $60.2M. GAAP diluted EPS was $0.25; adjusted diluted EPS was $0.36. The company raised full-year 2026 guidance: revenue $1,171.1M–$1,190.1M (vs. prior $1,171M–$1,175M implied), adjusted EPS $1.34–$1.41, and adjusted EBITDA $94.4M–$98.0M. Growth was driven by acquisitions (offsetting headwinds: Medicare reimbursement declines, transition costs of $2.5M in Q2 from UnitedHealth integration).
Why this rating
Strong organic and acquisition-driven growth with raised guidance; UnitedHealth integration on track. Relative to ~$1B market cap, $78.5M incremental Q2 revenue is material; however, Medicare exposure and integration risks limit trajectory-change potential.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.